Andrographolide__Apoptosis Inducer Canagliflozin
Product Name
Andrographolide
Description
Apoptosis Inducer
Purity
>98%
CAS No.
5508-58-7
Molecular Formula
C20H30O5
Molecular Weight
350.45
Storage Temperature
-20ºC
Shipping Temperature
Shipped Ambient
Product Type
Inducer
Solubility
DMSO
Source
Synthetic
Appearance
Off-white Solid
SMILES
OC3COC(=O)C3=CC[C@@H]1C(=C)CC[C@@H]2C(C)(CO)[[email protected]](O)CC[C@@]12C
InChI
InChI=1S/C20H30O5/c1-12-4-7-16-19(2,9-8-17(23)20(16,3)11-21)14(12)6-5-13-15(22)10-25-18(13)24/h5,14-17,21-23H,1,4,6
InChIKey
BOJKULTULYSRAS-OTESTREVSA-N
Safety Phrases
Classification: Caution: Substance not yet fully tested.
Safety Phrases:
S22 – Do not breathe dust
S24/25 – Avoid contact with skin and eyes
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection
Cite This Product
Andrographolide (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-220)
References PubMed ID::http://www.ncbi.nlm.nih.gov/pubmed/19114223
Alternative Names
(3E)-4-Hydroxy-3-{2-[(1R,4aS,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydro-1-naphthalenyl]ethylidene}dihydro-2(3H)-furanone
Research Areas
Cancer, Apoptosis
PubChem ID
5318517
Scientific Background
Andrographolide is a labdane diterpenoid that is the main bioactive component of the medicinal plant Andrographis paniculata. Is has been shown to be effective against certain cancers, and is an effective purgative (1). It blocks T-cell proliferation to allogenic stimuli and the chemotactic migration of macrophages induced by complement (2, 3).
References
1. Chakravarti R.N., Chakravarti D. (1951) Ind. Med Gaz. 86(3): 96-7.
2. Tsai H.R., et al. (2004) Eur J Pharmacol. 498: 45-52.
3. Rajagopal S., et al. (2003) J Exp. Ther. Oncol. 3: 147-158.
Apoptosis Inducer
Safety Phrases:
S22 – Do not breathe dust
S24/25 – Avoid contact with skin and eyes
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection
2. Tsai H.R., et al. (2004) Eur J Pharmacol. 498: 45-52.
3. Rajagopal S., et al. (2003) J Exp. Ther. Oncol. 3: 147-158.